Literature DB >> 24028331

The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010.

Z M Younossi1, M Stepanova, A Mishra, C Venkatesan, L Henry, S Hunt.   

Abstract

BACKGROUND: As baby boomers age, chronic hepatitis C (CHC) will become increasingly important in Medicare eligible group. AIM: To evaluate trends in Medicare resource utilisation for CHC.
METHODS: We analysed the Medicare in-patient and out-patient data from 2005 to 2010. For each patient, all claims with CHC as a principal diagnosis were added up and yearly CHC-related spending was calculated.
RESULTS: A total of 48,880 out-patient claims for 21,655 CHC patients and 4884 hospital admission claims for 3092 patients were included. The number of in-patient (1.5-1.6/year) or out-patient (2.2-2.3/year) visits per patient did not change over time, nor did the demographic characteristics of the CHC population. The majority of this population was eligible for Medicare based on disability and the average number of diagnoses per in-patient claim (from 8.11 in 2005 to 8.60 in 2010) and per out-patient claim (from 2.18 in 2005 to 2.71 in 2010) increased (both P < 0.0001). The average total yearly spending per patient increased in the out-patient setting from $488 in 2005 to $584 in 2010 (P = 0.0132) and did not change in the in-patient setting (from $22,245 in 2005 to $23,383 in 2010, P = 0.14). In the multivariate analysis, the number of diagnoses and conditions per claim and the number of in-patient or out-patient procedures per year were the important independent predictors of increased resource utilisation.
CONCLUSIONS: Most Medicare beneficiaries with chronic hepatitis C who sought in-patient or out-patient care in 2005-2010 had received Medicare for disability. Although the total resource utilisation did not change, the proportion of patient's responsibility increased.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 24028331     DOI: 10.1111/apt.12485

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

1.  Resource utilization and survival among Medicare patients with advanced liver disease.

Authors:  Munkhzul Otgonsuren; Linda Henry; Sharon Hunt; Chapy Venkatesan; Alita Mishra; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2014-08-10       Impact factor: 3.199

Review 2.  Dermatologic Extrahepatic Manifestations of Hepatitis C.

Authors:  Bhavtosh Dedania; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

Review 3.  New insights into HCV-related rheumatologic disorders: A review.

Authors:  Patrice Cacoub; Cloé Comarmond
Journal:  J Adv Res       Date:  2016-07-25       Impact factor: 10.479

4.  Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study.

Authors:  Zobair M Younossi; Li Zheng; Maria Stepanova; Chapy Venkatesan; Alita Mishra
Journal:  BMJ Open       Date:  2014-05-16       Impact factor: 2.692

Review 5.  HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape.

Authors:  Nancy Reau; Michael W Fried; David R Nelson; Robert S Brown; Gregory T Everson; Stuart C Gordon; Ira M Jacobson; Joseph K Lim; Paul J Pockros; K Rajender Reddy; Kenneth E Sherman
Journal:  Liver Int       Date:  2015-11-22       Impact factor: 5.828

6.  Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.

Authors:  Alejandro Álvaro-Meca; María A Jiménez-Sousa; Alexandre Boyer; José Medrano; Holger Reulen; Thomas Kneib; Salvador Resino
Journal:  BMC Infect Dis       Date:  2016-03-12       Impact factor: 3.090

7.  Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations.

Authors:  Mohamed El Kassas; Osama Mo Hegazy; Eman M Salah
Journal:  World J Hepatol       Date:  2020-10-27

8.  Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States.

Authors:  Pegah Golabi; Munkhzul Otgonsuren; Winnie Suen; Aaron B Koenig; Bashir Noor; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.